Literature DB >> 370017

Strain specificity of opsonins for group B streptococci types II and III.

A O Shigeoka, R T Hall, H R Hill.   

Abstract

Strains of types II and III group B streptococci do not appear to be uniformly susceptible to opsonization by antibody-containing human sera, as studied using both a chemiluminescence and a radiolabeled bacterial uptake technique. We could not demonstrate a correlation of serum-sensitive or resistant strains with capsular antigen quantities, although serum absorption studies with whole organisms and HCl, trichloroacetic acid, and saline extracts indicated that the antibody to type-specific capsular polysaccharide is important in opsonizing both serum-resistant and serum-sensitive strains. Since trypsin treatment produced significantly enhanced opsonization of serum-resistant and serum-sensitive strains, proteins present on some group B streptococci may be important antiphagocytic factors.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 370017      PMCID: PMC414184          DOI: 10.1128/iai.23.2.438-445.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Role of antibody and complement in opsonization of group B streptococci.

Authors:  A O Shigeoka; R T Hall; V G Hemming; C D Allred; H R Hill
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

2.  NEONATAL SEPSIS AND OTHER INFECTIONS DUE TO GROUP B BETA-HEMOLYTIC STREPTOCOCCI.

Authors:  T C EICKHOFF; J O KLEIN; A K DALY; D INGALL; M FINLAND
Journal:  N Engl J Med       Date:  1964-12-10       Impact factor: 91.245

3.  The role of the capsular polysaccharide in the activation of the alternative pathway by the pneumococcus.

Authors:  J A Winkelstein; J A Bocchini; G Schiffman
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

4.  The spectrum of group B streptococcal infections in infancy.

Authors:  J B Howard; G H McCracken
Journal:  Am J Dis Child       Date:  1974-12

5.  Serious infections in adults due to group B streptococci. Clinical and serotypic characterization.

Authors:  A S Bayer; A W Chow; B F Anthony; L B Guze
Journal:  Am J Med       Date:  1976-10       Impact factor: 4.965

6.  Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci.

Authors:  R S Baltimore; D L Kasper; C J Baker; D K Goroff
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

7.  Pneumonia in the neonate associated with group B streptococcal septicemia.

Authors:  V G Hemming; D W McCloskey; H R Hill
Journal:  Am J Dis Child       Date:  1976-11

8.  The role of encapsulation and host age in the clearance of Haemophilus influenzae bacteremia.

Authors:  P F Weller; A L Smith; P Anderson; D H Smith
Journal:  J Infect Dis       Date:  1977-01       Impact factor: 5.226

9.  Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence.

Authors:  V G Hemming; R T Hall; P G Rhodes; A O Shigeoka; H R Hill
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

10.  Multiple polysaccharide antigens of group B streptococcus, type Ia: emphasis on a sialic acid type-specific polysaccharide.

Authors:  J A Kane; W W Karakawa
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

View more
  12 in total

1.  Receptors for fibrinogen and aggregated beta 2-microglobulin detected in strains of group B streptococci.

Authors:  C Schönbeck; L Björck; G Kronvall
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

2.  Possible virulence marker for Streptococcus agalactiae (Lancefield Group B).

Authors:  G Orefici; S Recchia; L Galante
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

3.  Impaired opsonophagocytosis of serotypes Ib and II of group B streptococci as compared with serotypes Ia and III: role of the alternative pathway of complement in opsonisation of serotype III of group B streptococci.

Authors:  P Hindocha; R Hill; C B Wood; U Patel; G Hunt
Journal:  J Clin Pathol       Date:  1984-07       Impact factor: 3.411

4.  Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci.

Authors:  M K Yeung; S J Mattingly
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

5.  Clinical versus laboratory strains of Group B streptococci and human neutrophil chemiluminescence.

Authors:  M J Kowolik; C G Cumming
Journal:  J Clin Pathol       Date:  1984-02       Impact factor: 3.411

6.  An alternative role for specific antibody in neutrophil bactericidal activity against highly pathogenic group B streptococci.

Authors:  P H Cleat; C R Coid
Journal:  Br J Exp Pathol       Date:  1982-08

7.  Enzyme-linked immunosorbent assay for group B streptococcal antibodies.

Authors:  N S Rote; N L Taylor; A O Shigeoka; J R Scott; H R Hill
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

8.  Bactericidal capacity of newborn phagocytes against group B beta-hemolytic streptococci.

Authors:  I D Becker; O M Robinson; T S Bazán; M López-Osuna; R R Kretschmer
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

9.  Type-specific capsular antigen is associated with virulence in late-onset group B Streptococcal type III disease.

Authors:  M E Klegerman; K M Boyer; C K Papierniak; L Levine; S P Gotoff
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

10.  Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci).

Authors:  C von Hunolstein; S D'Ascenzi; B Wagner; J Jelínková; G Alfarone; S Recchia; M Wagner; G Orefici
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.